Nomura Holdings
OCUL icon

Nomura Holdings’s Ocular Therapeutix OCUL Stock Holding History

Nomura Holdings’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-86,000
Closed -$1.04M – 2001
2025
Q4 		$1.04M Buy
86,000
+39,700
+86% +$482K ﹤0.01% 1327
2025
Q3 		$541K Buy
+46,300
New +$554K ﹤0.01% 1579

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VR Adviser
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nomura Holdings's OCUL Position: Q2 2026 in Review

Nomura Holdings sold out of Ocular Therapeutix (OCUL) in Q2 2026, closing a stake of 50,000 shares — an estimated $424K sold.

Nomura Holdings first reported a position in OCUL in Q1 2026 and held it in 1 quarter. The position peaked at $424K in Q1 2026. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Nomura Holdings reported no remaining Ocular Therapeutix position as of Q2 2026 after selling out during the quarter.
  • Nomura Holdings sold 50,000 Ocular Therapeutix shares in Q2 2026, an estimated $424K.
  • Nomura Holdings first reported a position in Ocular Therapeutix in Q1 2026 and held it in 1 quarter.
  • Nomura Holdings's Ocular Therapeutix position peaked at $424K in Q1 2026.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.